Small molecule FL118 is another promising anti-cancer agent inhibiting multiple cancer-associated survival and treatment-resistant proteins, including survivin, Mcl-1, XIAP, cIAP2, and MdmX 74. The gene discussed is MCL1; the disease is cancer.